Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2020-11-02 Regulatory Filings
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a notification released via RNS (Regulatory News Service) and explicitly states the purpose is to notify the market of the 'Total Voting Rights' as of the announcement date, citing DTR 5.6.1R. This notification details the total number of issued ordinary shares with voting rights (108,093,861). This type of announcement, which concerns the denominator for shareholder interest calculations under disclosure rules, is a specific regulatory update. While it relates to share capital, it is not a transaction (POS) or a general capital change (SHA), but rather a mandatory disclosure regarding voting rights. Since it is a specific regulatory announcement that doesn't fit perfectly into the other categories like DIV, DIRS, or MRQ (which usually reports changes in ownership thresholds), and it is clearly a regulatory filing disseminated via RNS, the most appropriate classification is RNS (Regulatory Filings) as a general regulatory update, or potentially SHA/POS if interpreted broadly, but RNS is the best fit for mandatory, non-financial-result regulatory updates.
2020-11-02 English
DECHRA PHARMACEUTICALS PLC - 2020 AGM - SPECIAL RESOLUTIONS PASSED
AGM Information Classification · 99% confidence The document explicitly states it contains 'RESOLUTIONS' passed at the 'Annual General Meeting of the Company duly convened and held on Tuesday 27 October 2020'. It details specific Ordinary and Special Resolutions concerning the authority to allot shares, rights issues, and share repurchases, all typical items voted upon and documented following an AGM. This content aligns perfectly with the definition of AGM Information, which covers presentations and materials shared during the Annual General Meeting.
2020-10-27 English
DECHRA PHARMACEUTICALS PLC - RESULT OF AGM
AGM Information Classification · 100% confidence The document explicitly states 'Results of Annual General Meeting (AGM)' and details the outcome of a poll held on various resolutions proposed at the AGM on October 27, 2020. This content directly corresponds to the definition of AGM Information, which reports on the proceedings and results of the Annual General Meeting. The code for this is AGM-R.
2020-10-27 English
Result of AGM
AGM Information Classification · 99% confidence The document explicitly states it contains the "Results of Annual General Meeting (AGM)" held on October 27, 2020. It details the voting outcomes (For, Against, Withheld) for 20 specific resolutions, which is the primary function of an AGM Results announcement. This directly matches the definition for AGM Information (AGM-R). Although it mentions that the results have been submitted to the National Storage Mechanism (NSM), the core content is the results themselves, not just the announcement of publication.
2020-10-27 English
Annual General Meeting - Trading Update
AGM Information Classification · 98% confidence The document explicitly mentions 'Annual General Meeting' (AGM) and provides details about the meeting taking place today, including the time and location. It also includes a 'Trading update' delivered prior to the AGM. Since the document is short (3573 chars) and serves as a pre-meeting update/statement delivered at the AGM, it strongly aligns with the 'AGM Information' category. Although it contains a trading update, the primary context and purpose stated is related to the AGM proceedings.
2020-10-27 English
Director/PDMR Shareholding
Remuneration Information Classification · 99% confidence The document explicitly states it is a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs)' concerning the 'Grant of SAYE options' to Directors (Ian Page and Paul Sandland). This type of filing, detailing personal share transactions by company directors and executives, directly matches the definition for Director's Dealing (DIRS). Although it is formatted as an RNS announcement, the core content is the insider transaction disclosure, making DIRS the most specific classification over the general RNS fallback.
2020-10-20 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.